Antibiotics are made through biological fermentation, chemical synthesis, or a combination of both, depending on the class of drug. The process is far more complex than growing mold in a petri dish. Even penicillin, which famously comes from a common fungus, took over a decade to go from Alexander Fleming’s 1929 discovery to a product that could actually treat a patient. Understanding how antibiotics are manufactured reveals why this isn’t something that can be safely replicated at home.
Two Fundamentally Different Production Routes
Not all antibiotics are made the same way. Some are natural products, manufactured by growing bacteria or fungi in large fermentation tanks. Penicillin, streptomycin, tetracycline, and erythromycin all fall into this category. The microorganisms produce these compounds naturally as chemical weapons against competing microbes, and industrial production essentially creates ideal conditions for that natural process at massive scale.
Other antibiotics are fully synthetic, built from scratch through chemical reactions in a lab. The sulfa drugs were among the first, and today the list includes important classes like quinolones (such as ciprofloxacin), carbapenems, and metronidazole. These compounds were designed by chemists rather than discovered in nature, and their production looks more like a chemical plant than a biology lab. A third category, semi-synthetic antibiotics, starts with a fermentation-produced compound that is then chemically modified to improve its effectiveness or reduce side effects.
How Fermentation-Based Antibiotics Are Produced
The process starts with a working cell bank: a carefully maintained collection of the specific microbial strain known to produce the desired antibiotic. A small sample is inoculated into a flask containing a growth medium designed to let the organism multiply without yet producing the antibiotic. This is the vegetative phase, focused purely on building up a large enough population of cells.
From that initial flask, the culture is transferred through a series of progressively larger vessels, each still containing vegetative medium, until there’s enough material to fill the final production fermenter. This scaling process can move from milliliter volumes in a lab flask up to thousands of liters in industrial tanks.
Here’s the counterintuitive part: the microorganisms don’t produce antibiotics while they’re actively growing. Antibiotic synthesis happens during the stationary phase, after the cells have used up a key nutrient like carbon, nitrogen, or phosphate. To control when this switch happens, manufacturers use slow-metabolizing nutrient sources. Instead of simple glucose, they feed the organisms complex starches, lactose, or soybean oil. Instead of pure nitrogen compounds, they use corn steep liquor, yeast extract, or soybean flour. The organisms burn through the easily digestible nutrients first to build cell mass, then shift into antibiotic production once those run out and only the slow-release nutrients remain.
Corn steep liquor, a waste product from cornstarch manufacturing, played a pivotal role in antibiotic history. When the Oxford research team brought penicillin production to the United States during World War II, substituting corn steep liquor into the growth medium produced exponentially more penicillin than anything achieved in England. That single ingredient change, combined with the development of deep-tank fermentation, made mass production possible.
From Raw Broth to Pure Compound
After fermentation, the antibiotic is dissolved in a messy biological soup filled with dead cells, leftover nutrients, proteins, and metabolic waste. Extracting the pure compound follows a classic sequence: filtration to remove solid debris, solvent extraction to pull the antibiotic into a separate liquid phase, and crystallization to isolate it as a pure solid.
Solvent extraction works by mixing the filtered broth with an organic solvent that the antibiotic preferentially dissolves into. The two liquids separate by gravity into distinct layers, and the antibiotic-rich layer is drawn off. A second round of extraction, sometimes with the addition of salts or alcohol, recovers the compound from the organic phase into a clean aqueous solution. The final crystallization step produces the raw antibiotic powder.
This powder still isn’t medicine. Turning it into a tablet requires additional ingredients: binders to hold the powder together, disintegrants to help the tablet break apart in your digestive system, coatings to protect the drug from stomach acid or control how quickly it releases, lubricants to keep the tablets from sticking to manufacturing equipment, and glidants to ensure the powder flows evenly during production. Each of these components must meet pharmaceutical purity standards, and the finished product must contain no less than 100 percent of the labeled amount of active ingredient.
Decades of Strain Improvement
The Penicillium mold that Fleming discovered produced tiny amounts of penicillin. The first patient treated with it, a policeman with a severe bacterial infection, died because the supply ran out before his treatment was complete. Since then, systematic strain improvement programs have increased penicillin productivity by more than 1,000-fold from the original strain.
These improvements come from multiple approaches. Increasing the number of copies of key biosynthetic genes in the fungus can boost output by 20 to 176 percent depending on which genes are duplicated and how many extra copies are introduced. Overexpressing individual genes involved in the production pathway has yielded increases ranging from 30 to 236 percent. One technique, combining specific cell-penetrating compounds with calcium chloride, boosted penicillin production 10 to 12-fold by ramping up expression of all three biosynthetic genes simultaneously. Modern production strains are the result of decades of this kind of incremental optimization stacked on top of itself.
How New Antibiotics Are Discovered
The traditional approach to finding new antibiotics starts with soil. Soil-dwelling bacteria, particularly a group called actinomycetes, are prolific producers of antimicrobial compounds. Researchers collect soil samples from various depths (from just below the surface down to about one meter), dry them in an oven, then suspend small amounts in sterile water and create a series of increasingly dilute solutions.
These dilutions are spread onto agar plates containing a specialized growth medium supplemented with antifungal agents to prevent contamination. After incubation at around 32°C for seven days, colonies that resemble known antibiotic-producing species are picked, purified through repeated cultivation, and preserved for testing.
Screening for antibiotic activity uses a straightforward method: each isolate is streaked in a line across an agar plate and incubated for five days to allow it to secrete any antimicrobial compounds into the surrounding medium. Then disease-causing bacteria are streaked perpendicular to the original line. After overnight incubation, researchers measure the clear zone where the test bacteria couldn’t grow. A larger zone means stronger antibiotic activity. In one study of 30 actinomycete strains isolated from soil samples in Bangladesh, this method identified multiple isolates with significant antibacterial effects.
Why DIY Antibiotic Production Is Dangerous
The internet occasionally surfaces guides for making penicillin at home, typically involving growing Penicillium mold on bread or citrus fruit and attempting to extract the compound. The problems with this approach are severe and overlapping.
First, the mold on your bread is almost certainly not the right strain. Even Fleming’s original Penicillium produced so little penicillin that a decade of focused scientific effort was needed before anyone could extract enough to treat a single patient. Wild molds also produce a range of toxic metabolites alongside any trace antibiotics. Without sophisticated purification equipment, there is no way to separate the desired compound from harmful byproducts.
Second, penicillin and related antibiotics are among the most common triggers of severe allergic reactions, including skin rashes, anaphylactic shock, kidney damage, and in rare cases Stevens-Johnson syndrome, a life-threatening skin condition. These reactions can occur even from small residual amounts. Taking an impure, unquantified extract dramatically increases the risk because you have no way to control the dose or know what else is in it.
Third, contamination with other microorganisms during uncontrolled fermentation can introduce entirely separate toxins. Some antibiotic residues and related compounds have demonstrated carcinogenic effects, bone marrow toxicity, kidney damage, and mutagenic properties. Chloramphenicol residues cause bone marrow suppression. Certain compounds in the same chemical families as common antibiotics have been linked to reproductive disorders and birth defects.
Finally, sub-therapeutic doses of antibiotics, which is what any crude home extraction would produce, are precisely the conditions that accelerate antibiotic resistance. You’d be unlikely to cure an infection while making future infections harder to treat.
The Scale Problem
Even if someone had the right strain and basic lab equipment, the gap between producing a detectable amount of antibiotic and producing a therapeutic dose is enormous. Research-scale fermentation typically operates in the range of a few liters, using precisely controlled bench-top bioreactors that maintain exact temperature, oxygen levels, pH, and nutrient feed rates. Industrial production uses deep-tank fermenters that hold thousands of liters, with environmental conditions monitored continuously.
Scale-up isn’t simply a matter of using a bigger container. As vessels get larger, mixing becomes uneven, creating zones where cells experience different oxygen and glucose levels. Research into these so-called oscillating conditions uses scale-down systems that mimic the inconsistencies found in large industrial bioreactors, testing whether production strains can tolerate them before committing to full-scale manufacturing. The engineering required to maintain consistent conditions across thousands of liters is a discipline unto itself, and each antibiotic requires its own optimized process.